CC vs. FMC, OLN, ASH, BCPC, HUN, IOSP, HWKN, NGVT, ECVT, and PRM
Should you be buying Chemours stock or one of its competitors? The main competitors of Chemours include FMC (FMC), Olin (OLN), Ashland (ASH), Balchem (BCPC), Huntsman (HUN), Innospec (IOSP), Hawkins (HWKN), Ingevity (NGVT), Ecovyst (ECVT), and Perimeter Solutions (PRM). These companies are all part of the "chemicals & allied products" industry.
FMC (NYSE:FMC) and Chemours (NYSE:CC) are both mid-cap basic materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, earnings, analyst recommendations, dividends and community ranking.
FMC received 82 more outperform votes than Chemours when rated by MarketBeat users. Likewise, 64.78% of users gave FMC an outperform vote while only 60.95% of users gave Chemours an outperform vote.
91.9% of FMC shares are held by institutional investors. Comparatively, 76.3% of Chemours shares are held by institutional investors. 0.9% of FMC shares are held by company insiders. Comparatively, 0.5% of Chemours shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
FMC has a net margin of 27.65% compared to FMC's net margin of -5.51%. FMC's return on equity of 46.67% beat Chemours' return on equity.
FMC pays an annual dividend of $2.32 per share and has a dividend yield of 4.2%. Chemours pays an annual dividend of $1.00 per share and has a dividend yield of 4.1%. FMC pays out 25.9% of its earnings in the form of a dividend. Chemours pays out -46.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
FMC has higher earnings, but lower revenue than Chemours. Chemours is trading at a lower price-to-earnings ratio than FMC, indicating that it is currently the more affordable of the two stocks.
In the previous week, Chemours had 1 more articles in the media than FMC. MarketBeat recorded 9 mentions for Chemours and 8 mentions for FMC. Chemours' average media sentiment score of 1.05 beat FMC's score of 0.69 indicating that FMC is being referred to more favorably in the media.
FMC has a beta of 0.88, suggesting that its share price is 12% less volatile than the S&P 500. Comparatively, Chemours has a beta of 1.82, suggesting that its share price is 82% more volatile than the S&P 500.
FMC presently has a consensus target price of $70.56, indicating a potential upside of 28.79%. Chemours has a consensus target price of $30.89, indicating a potential upside of 26.70%. Given Chemours' stronger consensus rating and higher probable upside, research analysts plainly believe FMC is more favorable than Chemours.
Summary
FMC beats Chemours on 14 of the 20 factors compared between the two stocks.
Get Chemours News Delivered to You Automatically
Sign up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Chemours Competitors List
Related Companies and Tools
